TrialThe Journal of dermatology2021

A phase 2b, randomized, double-blind, multicenter, vehicle-controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild-to-moderate atopic dermatitis.

Kayo Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.